🔎 Trials Near Me

Domov › Rakovina (všetky typy) › Washington

Klinické štúdie Rakovina (všetky typy) v štáte Washington

58 štúdií pre Rakovina (všetky typy) hľadá účastníkov v zariadeniach v štáte Washington.

Mestá v štáte Washington

Oficiálny text štúdie (anglicky)

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

  • Fred Hutchinson Cancer Center. /ID# 277939, Seattle
  • Northwest Cancer Specialists - Vancouver /ID# 277855, Vancouver
Prebieha náborFáza 2/3
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07155187

Registry Study for Radiation Therapy Outcomes

  • University of Washington, Seattle
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT01255748

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • Fred Hutchinson Cancer Center, Seattle
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT04981119

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • Virginia Mason Medical Center, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center, Seattle
Prebieha náborFáza 2/3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06989437

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

  • Swedish Cancer Institute, Seattle
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06150157

A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

  • Seattle Children's Hospital, Seattle
Prebieha nábor
Vek 15 až 24 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT07223463

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

  • Fred Hutchinson Cancer Center ( Site 0106), Seattle
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07405164

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • Northwest Medical Specialties, Bonney Lake
  • Northwest Medical Specialties, Federal Way
  • Northwest Medical Specialties, Gig Harbor
  • a 4 ďalších
Prebieha náborFáza 2
Vek 12 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT02693535

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • Swedish Cancer Institute, Seattle
  • Fred Hutchinson Cancer Center, Seattle
Prebieha náborFáza 2/3
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT03435796

Collection of Tissue Samples for Cancer Research

  • Fred Hutchinson, Seattle
Prebieha náborObservačná štúdia
2 Months · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT00900198

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Seattle Neuropsychiatric Treatment Center, Seattle
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07002034

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

  • Northwest Medical Specialties Tacoma /ID# 272506, Tacoma
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT06953960

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

  • Investigational Site Number: 400, Seattle
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 10. 9. 2026 · NCT05997615

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • Fred Hutchinson Cancer Center, Seattle
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT06253871

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Swedish Cancer Institute - Edmonds, Edmonds
  • Kadlec Clinic Hematology and Oncology, Kennewick
  • Swedish Medical Center, Seattle
  • a 2 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06119581

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

  • Cancer Care Northwest, Spokane
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT07169851

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

  • University of Washington, Seattle
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06163534

Prostate Active Surveillance Study

  • Veterans Affairs Puget Sound Health Care System, Seattle
  • University of Washington, Seattle
Prebieha náborObservačná štúdia
Vek 21 a viac · Muži · Aktualizované 2. 9. 2026 · NCT00756665

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Cancer Care Northwest-1 (601 S. Sherman), Spokane
  • Cancer Care Northwest_2 (605 E. Holland), Spokane
  • Cancer Care Northwest, Spokane Valley
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06072612

A Study of ARC-02 in B-cell NHL

  • Summit Cancer Centers - North Spokane, Spokane
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT07691606

Project: Every Child for Younger Patients With Cancer

  • Seattle Children's Hospital, Seattle
  • Providence Sacred Heart Medical Center and Children's Hospital, Spokane
  • Mary Bridge Children's Hospital and Health Center, Tacoma
  • a 1 ďalších
Prebieha náborObservačná štúdia
Do veku 25 · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT02402244

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

  • Swedish Cancer Institute, Seattle
  • Fred Hutchinson Cancer Center, Seattle
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT04104776

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT04515810

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

  • Fred Hutchinson Cancer Center, Seattle
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 10. 8. 2026 · NCT06067841

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

  • Seattle Children's Hospital Research Foundation, Seattle
Prebieha náborFáza 2
Vek 1 až 39 · Všetky pohlavia · Aktualizované 7. 8. 2026 · NCT05999994

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Providence Regional Cancer System-Aberdeen, Aberdeen
  • PeaceHealth Saint Joseph Medical Center, Bellingham
  • Providence Regional Cancer System-Centralia, Centralia
  • a 20 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 8. 2026 · NCT06580314

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

  • Seattle Children's Hospital, Seattle
Prebieha náborFáza 2
Vek 1 až 26 · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT07680439

Resilience Mobile App for Teens and Young Adults With Cancer

  • Seattle Children's Hospital, Seattle
Prebieha nábor
Vek 12 až 25 · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT05842902

A Study of ASP1002 in Adults for Treatment of Solid Tumors

  • Swedish Cancer Institute, Edmonds
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 7. 2026 · NCT05719558

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

  • Fred Hutchinson Cancer Center. /ID# 267940, Seattle
  • Northwest Medical Specialties Tacoma /ID# 267117, Tacoma
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 7. 2026 · NCT05650632

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

  • Fred Hutchinson Cancer Research Center, Seattle
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 6. 2026 · NCT06162221

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

  • GSK Investigational Site, Seattle
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 6. 2026 · NCT06431594

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • Fred Hutchinson Cancer Center, Seattle
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 6. 2026 · NCT06993844

Childhood Cancer Survivor Study

  • Seattle Children's Hospital, Seattle
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 17. 6. 2026 · NCT01120353

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Prebieha nábor
Vek 18 až 75 · Všetky pohlavia · Aktualizované 17. 6. 2026 · NCT05486572

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

  • Fred Hutchinson Cancer Center, Seattle
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 6. 2026 · NCT06051695

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

  • Fred Hutchinson Cancer Center, Seattle
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 5. 2026 · NCT03686124

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.